{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:33:03Z","timestamp":1793395983106,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["17-27514Y"],"award-info":[{"award-number":["17-27514Y"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV 260 401, 260 414"],"award-info":[{"award-number":["SVV 260 401, 260 414"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Slovak Grant Agency","award":["VEGA 1\/0284\/15"],"award-info":[{"award-number":["VEGA 1\/0284\/15"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.017","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:05:09Z","timestamp":1523361909000},"page":"824-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action"],"prefix":"10.1016","volume":"151","author":[{"given":"Rudolf","family":"Vos\u00e1tka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kr\u00e1tk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"\u0160varcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Janou\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Stola\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Madacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Husz\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katar\u00edna","family":"Miku\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kordul\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franti\u0161ek","family":"Trejtnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-8409","authenticated-orcid":false,"given":"Jarmila","family":"Vin\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.017_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/emmm.201201772","article-title":"Tuberculosis drug discovery in the post-post-genomic era","volume":"6","author":"Lechartier","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2018.04.017_bib2","unstructured":"World Health Organization, Global Tuberculosis Report 2016, http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ (Accessed 19.4.17)."},{"key":"10.1016\/j.ejmech.2018.04.017_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.micro.61.111606.122346","article-title":"The mechanism of isoniazid killing: clarity through the scope of genetics","volume":"61","author":"Vilcheze","year":"2007","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2018.04.017_bib4","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/jac\/dkt090","article-title":"High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations","volume":"68","author":"Machado","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.04.017_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-8579(99)00111-9","article-title":"Drug resistant and multidrug-resistant tubercle bacilli","volume":"13","author":"Petrini","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2018.04.017_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2017.04.002","article-title":"Isoniazid derivatives and their anti-tubercular activity","volume":"133","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bmc.2014.12.038","article-title":"Synthesis and biological activities of some new isonicotinic acid 2-(2-hydroxy-8-substituted-tricyclo[7.3.1.02,7]tridec-13-ylidene)-hydrazides","volume":"23","author":"Matei","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1039\/C4MD00288A","article-title":"Novel isoniazid-amidoether derivatives: synthesis, characterization and antimycobacterial activity evaluation","volume":"6","author":"Kumar","year":"2015","journal-title":"Med. Chem. Commun"},{"key":"10.1016\/j.ejmech.2018.04.017_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2014.05.005","article-title":"Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in\u00a0vitro and in\u00a0vivo antimycobacterial activity evaluation","volume":"81","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejmech.2014.04.077","article-title":"Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity","volume":"81","author":"Martins","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib11","first-page":"815","article-title":"Structural and in\u00a0vitro anti-tubercular activity study of (E)-N'-(2,6-dihydroxybenzylidene)nicotinohydrazide and some transition metal complexes","volume":"12","author":"Ogunniran","year":"2015","journal-title":"J.\u00a0Iran. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.04.017_bib12","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1007\/s00044-014-1020-2","article-title":"Synthesis of novel isoniazid incorporated styryl quinazolines as anti-tubercular agents against INH sensitive and MDR M.\u00a0tuberculosis strains","volume":"23","author":"Babu","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.04.017_bib13","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.1039\/C4RA14440F","article-title":"Novel hybrid-pyrrole derivatives: their synthesis, antitubercular evaluation and docking studies","volume":"5","author":"Saha","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.04.017_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cclet.2015.01.008","article-title":"Potential anti-tubercular agents: hexahydro-3-phenyl indazol-2-yl(pyridin-4-yl)methanones from anti-tubercular drug isoniazid and bis(substituted-benzylidene)cycloalkanones","volume":"26","author":"Napoleon","year":"2015","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.04.017_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152108783329780","article-title":"Recent advances on isoniazide derivatives","volume":"7","author":"Vin\u0161ov\u00e1","year":"2008","journal-title":"Anti-Infect. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib16","series-title":"Development of New MDR-TB Drugs","author":"Vin\u0161ov\u00e1","year":"2010"},{"key":"10.1016\/j.ejmech.2018.04.017_bib17","first-page":"511","article-title":"Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis \u2013 a review","volume":"355","author":"Scior","year":"2003","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2018.04.017_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/med.21262","article-title":"Antituberculosis drug research: a critical overview","volume":"33","author":"Beena","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.04.017_bib19","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.bmc.2007.01.051","article-title":"A\u00a0new modification of anti-tubercular active molecules","volume":"15","author":"Imramovsk\u00fd","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib20","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1016\/j.ejmech.2011.09.054","article-title":"New series of isoniazid hydrazones linked with electron-withdrawing substituents","volume":"46","author":"Vav\u0159\u00edkov\u00e1","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib21","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.3390\/molecules19043851","article-title":"N-substituted 2-isonicotinoylhydrazinecarboxamides \u2013 new anti-mycobacterial active molecules","volume":"19","author":"Rychtar\u010d\u00edkov\u00e1","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.04.017_bib22","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.ejmech.2011.07.052","article-title":"New fluorine-containing hydrazones active against MDR-tuberculosis","volume":"46","author":"Vav\u0159\u00edkov\u00e1","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib23","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1016\/j.bmc.2007.05.053","article-title":"Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines","volume":"15","author":"Navarrete-Vazquez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib24","first-page":"763","article-title":"Synthesis and anti-mycobacterial activity of new 4-thiazolidinone and 1,3,4-oxadiazole derivatives of isoniazid","volume":"71","author":"Bhat","year":"2014","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejmech.2018.04.017_bib25","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1016\/j.bmc.2005.03.013","article-title":"Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations","volume":"13","author":"Mamolo","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib26","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1128\/AAC.02896-15","article-title":"Oxadiazoles have butyrate-specific conditional activity against Mycobacterium tuberculosis","volume":"60","author":"Early","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.04.017_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2018.04.017_bib28","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1016\/j.bmcl.2012.08.061","article-title":"Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent","volume":"22","author":"Rane","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.04.017_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pupt.2015.03.004","article-title":"Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis","volume":"32","author":"Mata-Espinosa","year":"2015","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2018.04.017_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2011.10.057","article-title":"Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents","volume":"21","author":"Ahsan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.04.017_bib31","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1021\/jm00172a015","article-title":"2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents","volume":"33","author":"Kane","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib32","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1021\/ja01637a054","article-title":"Chemotherapy of experimental tuberculosis. 10. Heterocyclic acyl derivatives of substituted semicarbazides","volume":"76","author":"Yale","year":"1954","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.04.017_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/jo01122a002","article-title":"Preparation of 5-substituted-1,3,4-oxadiazol-2(3H)ones and their reactions","volume":"20","author":"Stempel","year":"1955","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib34","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/jo2025509","article-title":"o-Iodoxybenzoic acid mediated oxidative desulfurization initiated domino reactions for synthesis of azoles","volume":"77","author":"Chaudhari","year":"2012","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.04.017_bib35","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.3390\/molecules18043674","article-title":"Antibacterial activity of salicylanilide 4-(Trifluoromethyl)-benzoates","volume":"18","author":"Kr\u00e1tk\u00fd","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.04.017_bib36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.43.5.1042","article-title":"Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis","volume":"43","author":"Phetsuksiri","year":"1999","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T18:41:56Z","timestamp":1571078516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418303507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":36,"alternative-id":["S0223523418303507"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.017","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}